Huanling Zhu
Sichuan University(CN)Kunming Medical University(CN)Nanjing General Hospital of Nanjing Military Command(CN)West China Hospital of Sichuan University(CN)Shandong Tumor Hospital(CN)Shandong First Medical University(CN)Dazhou Central Hospital(CN)
Publications by Year
Research Areas
Chronic Myeloid Leukemia Treatments, Chronic Lymphocytic Leukemia Research, Myeloproliferative Neoplasms: Diagnosis and Treatment, Eosinophilic Disorders and Syndromes, Lymphoma Diagnosis and Treatment
Most-Cited Works
- → Phase 3 study of nilotinib vs imatinib in Chinese patients with newly diagnosed chronic myeloid leukemia in chronic phase: ENESTchina(2015)108 cited
- → Potential role of exosome-associated microRNA panels and in vivo environment to predict drug resistance for patients with multiple myeloma(2016)104 cited
- → Olverembatinib (HQP1351), a well-tolerated and effective tyrosine kinase inhibitor for patients with T315I-mutated chronic myeloid leukemia: results of an open-label, multicenter phase 1/2 trial(2022)93 cited
- → Comparison of entecavir and lamivudine in preventing hepatitis B reactivation in lymphoma patients during chemotherapy(2010)92 cited
- → Multicenter, Randomized, Open-Label Study Comparing the Efficacy and Safety of Micafungin versus Itraconazole for Prophylaxis of Invasive Fungal Infections in Patients undergoing Hematopoietic Stem Cell Transplant(2012)78 cited